BofA lifts HCA Healthcare price target to $540 while maintaining Neutral rating
BofA Securities raised its price target on HCA Healthcare to $540 from $485 and left its rating at Neutral. The change reflects the firm's read of HCA's 2026 guidance, which projects modest growth and excludes potential Supplemental Directed Payment receipts that could materially boost results. HCA reported a fourth-quarter earnings beat on EPS but…